FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023562341> ?p ?o ?g. }

• W2023562341 endingPage "774" @default.
• W2023562341 startingPage "769" @default.
• W2023562341 abstract "There have been no reports concerning the efficacy and safety of a 1-week quadruple therapy regimen of omeprazole, amoxycillin, roxithromycin and metronidazole for Helicobacter pylori infections and the impact of primary resistance on the eradication rate.One hundred and sixty-nine consecutive patients with peptic ulcer disease as well as gastritis with biopsy-proven H. pylori infection were entered into an open study of omeprazole 20 mg o.m., amoxycillin 500 mg t.d.s., roxithromycin 150 mg b.d., and metronidazole 250 mg t.d.s. Helicobacter pylori status was determined by urease test, histology and culture. Susceptibility to amoxycillin, metronidazole and roxithromycin was determined by the E-test.H. pylori was eradicated in 155 out of 169 (92%; 95% CI 88-96%) by intention-to-treat analysis, and in 155 out of 163 (95%; 95% CI 92-98%) by per protocol analysis. The prevalence of primary resistance against amoxycillin, roxithromycin and metronidazole was 2 out of 166 (1%), 16 out of 166 (10%) and 27 out of 166 (16%), respectively. H. pylori was eradicated in 25 out of 27 (93%) patients with metronidazole-resistant strains compared with 130 out of 136 (96%) in patients with metronidazole-sensitive strains of H. pylori. It was eradicated in 15 out of 16 (94%) patients with roxithromycin-resistant strains while in 140 out of 147 (95%) patients with roxithromycin-sensitive strains of H. pylori, and in two out of two (100%) patients with amoxycillin-resistant stains compared with 153 out of 161 (95%) in patients with amoxycillin-sensitive strains. H. pylori was eradicated in three out of four (75%) patients with double resistance against metronidazole and roxithromycin compared with 152 out of 159 (96%) patients with sensitive strains to metronidazole and or roxithromycin. None of these differences were statistically significant. Severe side-effects were found in only one out of 169 patients-anaphylaxis due to penicillin.The 1-week quadruple therapy with omeprazole, amoxycillin, metronidazole and roxithromycin was found to eradicate H. pylori in over 90% of all patients. This regimen was also found to be beneficial for patients with pre-treatment resistant strains to metronidazole, roxithromycin or amoxycillin, and was observed to be safe and well-tolerated." @default.
• W2023562341 created "2016-06-24" @default.
• W2023562341 creator A5002687400 @default.
• W2023562341 creator A5003393934 @default.
• W2023562341 creator A5006827903 @default.
• W2023562341 creator A5018546113 @default.
• W2023562341 creator A5051510459 @default.
• W2023562341 creator A5052484414 @default.
• W2023562341 creator A5062710592 @default.
• W2023562341 creator A5064841001 @default.
• W2023562341 date "1999-06-01" @default.
• W2023562341 modified "2023-09-26" @default.
• W2023562341 title "A new quadruple therapy for <i>Helicobacter pylori</i> : influence of resistant strains on treatment outcome" @default.
• W2023562341 cites W1652503284 @default.
• W2023562341 cites W1964065632 @default.
• W2023562341 cites W1974815028 @default.
• W2023562341 cites W1990253836 @default.
• W2023562341 cites W1997397480 @default.
• W2023562341 cites W2002526633 @default.
• W2023562341 cites W2006858201 @default.
• W2023562341 cites W2019815239 @default.
• W2023562341 cites W2020821171 @default.
• W2023562341 cites W2023177431 @default.
• W2023562341 cites W2024692727 @default.
• W2023562341 cites W2030545043 @default.
• W2023562341 cites W2048076239 @default.
• W2023562341 cites W2050476973 @default.
• W2023562341 cites W2052182033 @default.
• W2023562341 cites W2069042155 @default.
• W2023562341 cites W2069481742 @default.
• W2023562341 cites W2070810968 @default.
• W2023562341 cites W2072103708 @default.
• W2023562341 cites W2080512699 @default.
• W2023562341 cites W2112768155 @default.
• W2023562341 cites W2121961138 @default.
• W2023562341 cites W2148899552 @default.
• W2023562341 cites W2150876701 @default.
• W2023562341 cites W2162819483 @default.
• W2023562341 cites W2162890832 @default.
• W2023562341 doi "https://doi.org/10.1046/j.1365-2036.1999.00551.x" @default.
• W2023562341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10383506" @default.
• W2023562341 hasPublicationYear "1999" @default.
• W2023562341 type Work @default.
• W2023562341 sameAs 2023562341 @default.
• W2023562341 citedByCount "60" @default.
• W2023562341 countsByYear W20235623412012 @default.
• W2023562341 countsByYear W20235623412013 @default.
• W2023562341 countsByYear W20235623412014 @default.
• W2023562341 countsByYear W20235623412015 @default.
• W2023562341 countsByYear W20235623412016 @default.
• W2023562341 countsByYear W20235623412018 @default.
• W2023562341 countsByYear W20235623412019 @default.
• W2023562341 countsByYear W20235623412020 @default.
• W2023562341 countsByYear W20235623412021 @default.
• W2023562341 countsByYear W20235623412022 @default.
• W2023562341 crossrefType "journal-article" @default.
• W2023562341 hasAuthorship W2023562341A5002687400 @default.
• W2023562341 hasAuthorship W2023562341A5003393934 @default.
• W2023562341 hasAuthorship W2023562341A5006827903 @default.
• W2023562341 hasAuthorship W2023562341A5018546113 @default.
• W2023562341 hasAuthorship W2023562341A5051510459 @default.
• W2023562341 hasAuthorship W2023562341A5052484414 @default.
• W2023562341 hasAuthorship W2023562341A5062710592 @default.
• W2023562341 hasAuthorship W2023562341A5064841001 @default.
• W2023562341 hasBestOaLocation W20235623411 @default.
• W2023562341 hasConcept C126322002 @default.
• W2023562341 hasConcept C2776409635 @default.
• W2023562341 hasConcept C2777396551 @default.
• W2023562341 hasConcept C2777498785 @default.
• W2023562341 hasConcept C2778423520 @default.
• W2023562341 hasConcept C2778677798 @default.
• W2023562341 hasConcept C2779708577 @default.
• W2023562341 hasConcept C2780206985 @default.
• W2023562341 hasConcept C2780708398 @default.
• W2023562341 hasConcept C2781413609 @default.
• W2023562341 hasConcept C501593827 @default.
• W2023562341 hasConcept C71924100 @default.
• W2023562341 hasConcept C86803240 @default.
• W2023562341 hasConcept C89423630 @default.
• W2023562341 hasConcept C90924648 @default.
• W2023562341 hasConceptScore W2023562341C126322002 @default.
• W2023562341 hasConceptScore W2023562341C2776409635 @default.
• W2023562341 hasConceptScore W2023562341C2777396551 @default.
• W2023562341 hasConceptScore W2023562341C2777498785 @default.
• W2023562341 hasConceptScore W2023562341C2778423520 @default.
• W2023562341 hasConceptScore W2023562341C2778677798 @default.
• W2023562341 hasConceptScore W2023562341C2779708577 @default.
• W2023562341 hasConceptScore W2023562341C2780206985 @default.
• W2023562341 hasConceptScore W2023562341C2780708398 @default.
• W2023562341 hasConceptScore W2023562341C2781413609 @default.
• W2023562341 hasConceptScore W2023562341C501593827 @default.
• W2023562341 hasConceptScore W2023562341C71924100 @default.
• W2023562341 hasConceptScore W2023562341C86803240 @default.
• W2023562341 hasConceptScore W2023562341C89423630 @default.
• W2023562341 hasConceptScore W2023562341C90924648 @default.
• W2023562341 hasIssue "6" @default.
• W2023562341 hasLocation W20235623411 @default.
• W2023562341 hasLocation W20235623412 @default.

• next